PRIMAL THERAPIES Trademark

Trademark Overview

On Wednesday, December 22, 2021, a trademark application was filed for PRIMAL THERAPIES with the United States Patent and Trademark Office. The USPTO has given the PRIMAL THERAPIES trademark a serial number of 97185940. The federal status of this trademark filing is NOT AVAILABLE as of Thursday, December 11, 2025. This trademark is owned by PRIMAL THERAPIES, INC.. The PRIMAL THERAPIES trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Research and development in the pharmaceutical and biotechnology fields
primal therapies

General Information

Serial Number97185940
Word MarkPRIMAL THERAPIES
Filing DateWednesday, December 22, 2021
Status610 - NOT AVAILABLE
Status DateThursday, December 11, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Goods and ServicesResearch and development in the pharmaceutical and biotechnology fields

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status CodeX - NOT AVAILABLE
Class Status DateThursday, December 11, 2025
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NamePRIMAL THERAPIES, INC.
Party Type11 - New Owner Before Publication
Legal Entity Type03 - Corporation
AddressMINNEAPOLIS, MN 55413
Party NameNOT AVAILABLE
Party Type10 - Original Applicant
Legal Entity Type01 - Individual
AddressMinneapolis, MN 55413
Party NameNOT AVAILABLE
Party Type10 - Original Applicant
Legal Entity Type01 - Individual
AddressMinneapolis, MN 55413

Trademark Events

Event DateEvent Description
Saturday, December 25, 2021NEW APPLICATION ENTERED
Wednesday, December 29, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, September 28, 2023TEAS CHANGE OF OWNER ADDRESS RECEIVED
Thursday, September 28, 2023APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Thursday, September 28, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, September 28, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, September 28, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, July 11, 2024AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Tuesday, August 20, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, August 20, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, August 20, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, August 20, 2024TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Friday, November 8, 2024ASSIGNED TO LIE
Friday, November 8, 2024APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Friday, November 8, 2024APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, September 17, 2025SHOW CAUSE ORDER
Wednesday, September 17, 2025SUSPENDED PENDING ADMINISTRATIVE REVIEW
Wednesday, September 17, 2025NOTICE OF SUSPENSION EMAILED - PENDING SCO
Thursday, December 11, 2025ORDER FOR SANCTIONS
Thursday, December 11, 2025ORDER FOR SANCTIONS - NOTICE EMAILED
Thursday, December 11, 2025TERMINATED AFTER SANCTIONS
Thursday, December 11, 2025NOTICE OF TERMINATION – EMAILED

Related Keywords

therapies primal fields biotechnology pharmaceutical development research